Skip to main content
VITA LIFE SCIENCES LIMITED.. logo

VITA LIFE SCIENCES LIMITED.. — Investor Relations & Filings

Ticker · VLS ISIN · AU000000VLS8 ASX Manufacturing
Open in API
Filings indexed 1,057 across all filing types
Latest filing 2026-04-29 Share Issue/Capital Cha…
Country AU Australia
Listing ASX VLS

About VITA LIFE SCIENCES LIMITED..

https://vitalifesciences.com/

Vita Life Sciences Limited is a healthcare company focused on the development, marketing, and distribution of vitamins, minerals, and nutritional supplements. The company operates primarily through its core brands, including VitaHealth and Herbs of Gold, offering a diverse range of health products designed to support general well-being, immunity, and specific health concerns. Its product portfolio encompasses herbal medicines, dietary supplements, and functional foods formulated using evidence-based research and high-quality ingredients. The company maintains a significant presence across the Asia-Pacific region, serving markets in Southeast Asia and Oceania. By leveraging a multi-channel distribution strategy, including pharmacies, health food stores, and online platforms, the company provides accessible health solutions to a broad consumer base.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - VLS 5 pages 16.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX announcement used to apply for quotation of securities. It details the application for quotation of securities previously issued under an employee incentive scheme where transfer restrictions have ceased. The document includes specifics about the securities, issue date, and issued capital following quotation. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement related to capital market activities. This fits the category of Share Issue/Capital Change announcements, as it concerns the quotation of securities and changes in issued capital.
2026-04-29 English
Change of Director's Interest Notice 2 pages 227.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in shareholding, including the number of shares disposed and acquired, nature of the transaction, and dates. There is no financial report, earnings data, or management discussion. The document is a formal notification of a director's personal share transactions, consistent with insider trading disclosures. This matches the definition of 'Director's Dealing' filings.
2026-04-29 English
Notice of General Meeting/Proxy Form 21 pages 839.5KB
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled “Notice of Annual General Meeting and Explanatory Statement” and consists of the Notice of Meeting, Explanatory Statement, and Proxy Form for Vita Life Sciences’ 2026 AGM. It is clearly materials sent to shareholders to inform them of the meeting resolutions and to solicit their votes. This matches the definition of a Proxy Solicitation & Information Statement rather than an AGM presentation or a financial report. Therefore the appropriate classification is PSI.
2026-04-27 English
Notification of buy-back - VLS 5 pages 15.3KB
Transaction in Own Shares Classification · 90% confidence The document is an ASX Appendix 3C notification detailing a share buy-back program (employee share scheme buy-back), including security class, number of shares to be repurchased, price, and key dates. This matches the definition for a company’s own share transaction announcement, classified as a Transaction in Own Shares (POS).
2026-04-27 English
Employee Share Buy Back 1 page 124.4KB
Transaction in Own Shares Classification · 92% confidence The document is an ASX Market Announcement titled “EMPLOYEE SHARE BUY BACK” and references filing Appendix 3C for the buy‐back of unquoted shares under the employee Long Term Incentive Plan. It details the company’s share repurchase (number of shares, price, cancellation), which aligns with a transaction in own shares. This is not a dividend notice, M&A, director dealing or general regulatory filing, but specifically a share repurchase announcement by the company. Thus it is classified as a Transaction in Own Shares (POS).
2026-04-27 English
Notification of cessation of securities - VLS 4 pages 14.7KB
Transaction in Own Shares Classification · 89% confidence The document is an ASX Appendix 3H form titled “Notification of cessation of securities,” detailing the cancellation of 51,804 ordinary fully paid shares due to an on-market buy-back and the consideration paid. This is a direct report of the company transacting in its own shares (buy-back). Under our taxonomy, this falls under “Transaction in Own Shares” (Code: POS).
2026-04-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.